Sientra's headquarters in Goleta. Sientra breast implants will return to U.S. doctors’ offices on March 1, almost five months after the Goleta breast implant company pulled its products off the U.S. market. Sientra made the announcement early Feb. 8 before markets opened. Investors took the news with trepidation, even though the stock traded up 15…